Valeant faces federal probe over patient assistance programs
October 15, 2015
For the past few months, Valeant Pharmaceuticals has been investigated for jacking up drug prices to new heights. Now, the probes are expanding to another of its business practices.
Last night, the beleaguered Canadian drug maker disclosed that federal prosecutors in New York and Boston are eyeing its patient assistant programs, a sign that has investors worried the company’s fast-growth business model may face unexpected and significant pressure.
No Comment